R

Revenio Group Oyj
OMXH:REG1V

Watchlist Manager
Revenio Group Oyj
OMXH:REG1V
Watchlist
Price: 26.64 EUR -0.82% Market Closed
Market Cap: 710.8m EUR
Have any thoughts about
Revenio Group Oyj?
Write Note

Revenio Group Oyj
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Revenio Group Oyj
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
R
Revenio Group Oyj
OMXH:REG1V
Cash & Cash Equivalents
€13.5m
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
19%
M
Modulight Oyj
OMXH:MODU
Cash & Cash Equivalents
€409k
CAGR 3-Years
-39%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
B
Bioretec Oy
OMXH:BRETEC
Cash & Cash Equivalents
€6.9m
CAGR 3-Years
45%
CAGR 5-Years
41%
CAGR 10-Years
N/A
O
Optomed Oyj
OMXH:OPTOMED
Cash & Cash Equivalents
€7.1m
CAGR 3-Years
-12%
CAGR 5-Years
29%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Cash & Cash Equivalents
€3m
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
B
Biohit Oyj
OMXH:BIOBV
Cash & Cash Equivalents
€1.8m
CAGR 3-Years
22%
CAGR 5-Years
7%
CAGR 10-Years
20%
No Stocks Found

Revenio Group Oyj
Glance View

Market Cap
708.5m EUR
Industry
Health Care

Revenio Group Oyj is a globally operating health technology, which engages in the detection of glaucoma, osteoporosis, skin cancer, and asthma. The company is headquartered in Vantaa, Etela-Suomen and currently employs 184 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.

REG1V Intrinsic Value
32.92 EUR
Undervaluation 19%
Intrinsic Value
Price
R

See Also

What is Revenio Group Oyj's Cash & Cash Equivalents?
Cash & Cash Equivalents
13.5m EUR

Based on the financial report for Sep 30, 2024, Revenio Group Oyj's Cash & Cash Equivalents amounts to 13.5m EUR.

What is Revenio Group Oyj's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
19%

Over the last year, the Cash & Cash Equivalents growth was -30%. The average annual Cash & Cash Equivalents growth rates for Revenio Group Oyj have been -6% over the past three years , -8% over the past five years , and 19% over the past ten years .

Back to Top